The fight against cancer has been waging on for years. There has been many wins during this time and there has been many losses. Cancer research is in a fairly good place because of all the advancements in medications. Seattle Genetics, a Washington-based oncology company, is one of the biggest and best cancer research institutions in the world. Of course, being this good didn’t come by chance. Seattle Genetics is controlled by one of the best in the business. The best in the business is Dr. Clay Siegall, and he has provided great leadership and balance to the company.
Siegall is well-known throughout the industry thanks to his extended education. The guy has literally worked with some of the top institutions such as the National Institute of Health, the National Cancer Institute and Bristol Meyers Squibb. Siegall has a heart of gold, and he has dealt with this dangerous disease from an up-close-and-personal accounting. While in college, Siegall’s father for stricken with cancer, and it was devastating to see how this illness can ravage the human body. At the time, cancer fighting medications weren’t as advanced as today’s medicines. There were many sickening days and numerous sickening nights of frustration. This is what shifted Siegall’s focus, but he has always had an interest for this type of work. Unfortunately, his father passed and Siegall knew that he had to do something to decrease the illnesses nasty side effects.
Clay Siegall is the CEO of Seattle Genetics as well as one of its founders. This company has a specialty for producing, for commercializing and for distributing targeted cancer therapies. These therapies are known as antibody-based therapies, and they are much more efficient at fighting cancer. What makes the situation even sweeter is that the medications drastically decreases side effects. As of today, these advanced medications are being used on a global level and Dr. Clay Siegall is in control of it all.